CorMedix CRMD
NASDAQ CRMD
$7.79 +0.22 (+2.91%)
At close: Oct 21, 2026 · 4:00 PM EDT

CorMedix (CRMD) EV to EBITDA (2025)

Updated

CorMedix's (CRMD) EV to EBITDA came in at 4.63 for Q4 2025, down 41.4% from the prior quarter.

Analysis

CorMedix (CRMD) EV to EBITDA (2025) Analysis & Trends

For FY2025, CorMedix's EV to EBITDA stood at 3.65.

  • According to Business Quant data, EV to EBITDA for the three prior quarters was 7.90 (Q3 2025), 14.60 (Q2 2025) and 22.77 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CorMedix 609.51 Mn -43.01 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.63
Sep 30, 2025 7.90
Jun 30, 2025 14.60
Mar 31, 2025 22.77
API Access

CorMedix EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CRMD&period=max&api_key=YOUR_API_KEY